Top Markets
#1 Everything Everything +22.22%
#2 MarsCoin MarsCoin +10.14%
#3 Akedo Akedo +9.38%
#4 EXOD EXOD +9.04%
#5 peaq peaq +8.07%
#6 Solstice Solstice +7.47%
#7 The Black Bull The Black Bull +7.04%
#8 ETHGas ETHGas +6.30%
#9 Pons Pons +6.23%
#10 Peapods Finance Peapods Finance +6.22%
Coin of the day
Everything Everything
Cài đặt
Ngôn ngữ
TIếNG VIệT
Tiền tệ
USD
Chủ đề
Ambrx Biopharma Inc. Ambrx Biopharma Inc.

Ambrx Biopharma Inc.

AMAM
Xếp hạng trong cổ phiếu #6975
Ambrx Biopharma Inc. operates as a clinical-stage biotechnology company focused... Ambrx Biopharma Inc. operates as a clinical-stage biotechnology company focused on the discovery and development of precisely engineered biologic medicines. The firm utilizes its unique expanded genetic code technology platform to create these advanced therapies. Leading its pipeline is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is currently undergoing evaluation in several clinical investigations. These include pivotal Phase 2/3 trials for the treatment of HER2-positive metastatic breast cancer and gastric cancer, alongside studies for other solid tumors. Additionally, Ambrx is progressing two earlier-stage drug candidates: ARX517, an anti-PSMA ADC, which is in a Phase 1 clinical trial for prostate cancer and other solid tumor indications; and ARX305, an anti-CD70 ADC, currently in investigational new drug (IND)-enabling studies for potential applications in renal cell carcinoma and other cancers. The company's portfolio also encompasses multiple immuno-oncology programs. Among these are ARX822, a fab-small molecule bispecific therapeutic in preclinical development for various cancers, and ARX102, an immuno-oncology IL-2 pathway agonist intended to stimulate the patient's immune system by targeting beta and gamma receptors on cytotoxic T cells. Founded in 2003 and headquartered in La Jolla, California, Ambrx Biopharma Inc. has established significant collaborations with various pharmaceutical partners, including Bristol Myers Squibb Company, AbbVie Inc., BeiGene, Sino Biopharmaceutical Co., Ltd., NovoCodex, and Elanco Animal Health.
Giá cổ phiếu
$28.00
Đồng bộ lần cuối: 2024-03-06
Vốn hóa thị trường
$1.77B
Thay đổi (1 ngày)
0.07%
Thay đổi (1 năm)
0.00%
Quốc gia
US
Giao dịch Ambrx Biopharma Inc. (AMAM)

Danh mục

Healthcare
Lịch sử giá cổ phiếu của Ambrx Biopharma Inc. (AMAM)
Giá đóng cửa cao nhất: $27.98 vào 2024-03-01

Giá đóng cửa thấp nhất: $17.04 vào 2021-06-01
Lịch sử giá cổ phiếu của Ambrx Biopharma Inc. từ 2021 đến 2026
Hiệu suất giá cổ phiếu hàng năm
Năm Hiệu suất
2024 106.47%
2023 700.38%
2022 -81.39%
2021 0.00%
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
Công ty Giá cổ phiếu Thay đổi 1năm% Quốc gia
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.36 39.87%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.06K 50.29%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.05 -12.83%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $140.81 475.44%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $765.25 7.74%
CH